Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial
Titel:
Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial
Auteur:
Negrier, Sylvie Rioux-Leclercq, Nathalie Ferlay, Céline Gross-Goupil, Marine Gravis, Gwenaëlle Geoffrois, Lionel Chevreau, Christine Boyle, Helen Rolland, Frederic Blanc, Ellen Ravaud, Alain Dermeche, Slimane Flechon, Aude Albiges, Laurence Pérol, David Escudier, Bernard